サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：HIV診断の世界市場 (2022-2028年)：市場予測 (検査タイプ・エンドユーザー別)・地域的展望・成長の潜在性・価格動向・市場シェア
市場調査レポート
商品コード
1071371

HIV診断の世界市場 (2022-2028年)：市場予測 (検査タイプ・エンドユーザー別)・地域的展望・成長の潜在性・価格動向・市場シェア

HIV Diagnostics Market Size By Test Type, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 150 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
HIV診断の世界市場 (2022-2028年)：市場予測 (検査タイプ・エンドユーザー別)・地域的展望・成長の潜在性・価格動向・市場シェア
出版日: 2022年04月08日
発行: Global Market Insights Inc.
ページ情報: 英文 150 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

HIV診断の市場は、低開発国および先進国においてHIV感染が増加していることから、2028年にかけて急成長が続くと予想されています。

また、家庭用診断キットの普及が進んでいること、政府機関や民間企業による効果的な診断技術の開発への注力などの要因も予測期間中の市場成長をさらに後押しすると予想されています。

検査タイプ別では、抗体検査の部門が2028年にかけて堅調な成長を示すと予測されています。同部門の成長は、主に低開発国や発展途上国における感染者数の急増に起因しています。また、エンドユーザー別では、新しい家庭用検査製品の開発により、家庭用の部門が2028年にかけて1.1%超のCAGRを記録すると予想されています。

当レポートでは、世界のHIV診断の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 HIV診断産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク＆課題
  • 成長の可能性の分析
  • COVID-19：影響分析
  • 規制状況
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 HIV診断市場：検査タイプ別

  • 主要動向
  • 抗体検査
  • ウイルス量検査
  • CD4検査

第5章 HIV診断市場：エンドユーザー別

  • 主要動向
  • 診断ラボ
  • 病院・クリニック
  • 家庭用
  • その他

第6章 HIV診断市場：地域別

  • 主要動向
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
  • アフリカ

第7章 企業プロファイル

  • 戦略ダッシュボード
  • Abbott
  • OraSure Technologies.
  • BD
  • BIONEER CORPORATION
  • bioMérieux SA
  • ChemBio Diagnostics Inc.
  • Qiagen
  • Roche Diagnostics
  • Cepheid
  • Omega Diagnostics
図表

Data Tables

  • TABLE 1 HIV diagnostics industry 360 degree synopsis, 2017 - 2028 (USD Million)
  • TABLE 2 HIV diagnostics market, 2017 - 2021 (USD Million)
  • TABLE 3 HIV diagnostics market, 2022 - 2028 (USD Million)
  • TABLE 4 HIV diagnostics market, by test type, 2017 - 2021 (USD Million)
  • TABLE 5 HIV diagnostics market, by test type, 2022 - 2028 (USD Million)
  • TABLE 6 HIV diagnostics market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 7 HIV diagnostics market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 8 HIV diagnostics market, by region, 2017 - 2021 (USD Million)
  • TABLE 9 HIV diagnostics market, by region, 2022 - 2028 (USD Million)
  • TABLE 10 Industry impact forces
  • TABLE 11 Antibody tests market size, by region, 2017 - 2021 (USD Million)
  • TABLE 12 Antibody tests market size, by region, 2022 - 2028 (USD Million)
  • TABLE 13 Viral load test market size, by region, 2017 - 2021 (USD Million)
  • TABLE 14 Viral load test market size, by region, 2022 - 2028 (USD Million)
  • TABLE 15 CD4 test market size, by region, 2017 - 2021 (USD Million)
  • TABLE 16 CD4 test market size, by region, 2022 - 2028 (USD Million)
  • TABLE 17 Diagnostic laboratories market size, by region, 2017 - 2021 (USD Million)
  • TABLE 18 Diagnostic laboratories market size, by region, 2022 - 2028 (USD Million)
  • TABLE 19 Hospitals & clinics market size, by region, 2017 - 2021 (USD Million)
  • TABLE 20 Hospitals & clinics market size, by region, 2022 - 2028 (USD Million)
  • TABLE 21 Home settings market size, by region, 2017 - 2021 (USD Million)
  • TABLE 22 Home settings market size, by region, 2022 - 2028 (USD Million)
  • TABLE 23 Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 24 Others market size, by region, 2022 - 2028 (USD Million)
  • TABLE 25 North America HIV diagnostics market size, by country, 2017 - 2021 (USD Million)
  • TABLE 26 North America HIV diagnostics market size, by country, 2022 - 2028 (USD Million)
  • TABLE 27 North America HIV diagnostics market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 28 North America HIV diagnostics market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 29 North America HIV diagnostics market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 30 North America HIV diagnostics market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 31 U.S. HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 32 U.S. HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 33 U.S. HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 34 U.S. HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 35 Canada HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 36 Canada HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 37 Canada HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 38 Canada HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 39 Europe HIV diagnostics market size, by country, 2017 - 2021 (USD Mn)
  • TABLE 40 Europe HIV diagnostics market size, by country, 2022 - 2028 (USD Mn)
  • TABLE 41 Europe HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 42 Europe HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 43 Europe HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 44 Europe HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 45 Russia HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 46 Russia HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 47 Russia HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 48 Russia HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 49 France HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 50 France HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 51 France HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 52 France HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 53 Spain HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 54 Spain HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 55 Spain HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 56 Spain HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 57 Italy HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 58 Italy HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 59 Italy HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 60 Italy HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 61 UK HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 62 UK HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 63 UK HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 64 UK HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 65 Germany HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 66 Germany HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 67 Germany HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 68 Germany HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 69 Asia Pacific HIV diagnostics market size, by country, 2017 - 2021 (USD Mn)
  • TABLE 70 Asia Pacific HIV diagnostics market size, by country, 2022 - 2028 (USD Mn)
  • TABLE 71 Asia Pacific HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 72 Asia Pacific HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 73 Asia Pacific HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 74 Asia Pacific HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 75 India HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 76 India HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 77 India HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 78 India HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 79 China HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 80 China HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 81 China HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 82 China HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 83 Latin America HIV diagnostics market size, by country, 2017 - 2021 (USD Mn)
  • TABLE 84 Latin America HIV diagnostics market size, by country, 2022 - 2028 (USD Mn)
  • TABLE 85 Latin America HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 86 Latin America HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 87 Latin America HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 88 Latin America HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 89 Brazil HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 90 Brazil HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 91 Brazil HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 92 Brazil HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 93 Mexico HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 94 Mexico HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 95 Mexico HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 96 Mexico HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 97 Argentina HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 98 Argentina HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 99 Argentina HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 100 Argentina HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 101 Middle East HIV diagnostics market size, by country, 2017 - 2021 (USD Mn)
  • TABLE 102 Middle East HIV diagnostics market size, by country, 2022 - 2028 (USD Mn)
  • TABLE 103 Middle East HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 104 Middle East HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 105 Middle East HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 106 Middle East HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 107 Iran HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 108 Iran HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 109 Iran HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 110 Iran HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 111 Saudi Arabia HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 112 Saudi Arabia HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 113 Saudi Arabia HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 114 Saudi Arabia HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 115 Yemen HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 116 Yemen HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 117 Yemen HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 118 Yemen HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 119 Africa HIV diagnostics market size, by country, 2017 - 2021 (USD Mn)
  • TABLE 120 Africa HIV diagnostics market size, by country, 2022 - 2028 (USD Mn)
  • TABLE 121 Africa HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 122 Africa HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 123 Africa HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 124 Africa HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 125 South Africa HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 126 South Africa HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 127 South Africa HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 128 South Africa HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 129 Mozambique HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 130 Mozambique HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 131 Mozambique HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 132 Mozambique HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 133 Nigeria HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 134 Nigeria HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 135 Nigeria HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 136 Nigeria HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 137 United Republic of Tanzania HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 138 United Republic of Tanzania HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 139 United Republic of Tanzania HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 140 United Republic of Tanzania HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 141 Kenya HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 142 Kenya HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 143 Kenya HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 144 Kenya HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)
  • TABLE 145 Uganda HIV diagnostics market size, by test type, 2017 - 2021 (USD Mn)
  • TABLE 146 Uganda HIV diagnostics market size, by test type, 2022 - 2028 (USD Mn)
  • TABLE 147 Uganda HIV diagnostics market size, by end-use, 2017 - 2021 (USD Mn)
  • TABLE 148 Uganda HIV diagnostics market size, by end-use, 2022 - 2028 (USD Mn)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global HIV diagnostics market size, 2017 - 2028 (USD Million)
  • FIG. 3 Growth potential analysis, by test type
  • FIG. 4 Growth potential analysis, by end-use
  • FIG. 5 Porter's analysis
  • FIG. 6 Competitive matrix analysis, 2021
  • FIG. 7 PESTEL analysis
  • FIG. 8 Key segment trends, by test type
  • FIG. 9 Key segment trends, by end-use
  • FIG. 10 Key regional trends
  • FIG. 11 Competitive dashboard, 2021
目次
Product Code: 491

The HIV diagnostics market is set to witness rapid growth through 2028 owing to rising HIV infections in under-developed and developed nations globally. In addition, rising adoption of home kits for diagnosis, along with increasing focus of government and private organizations on the development of effective diagnosis techniques, is anticipated to further drive the growth of the market over the forecast timeline.

According to the World Health Organization (WHO), in 2020, around 37.7 million people across the globe were living with HIV. Notably, nearly 40% of HIV infections are transmitted by people who are unaware that they have the virus. For people who have not been diagnosed, HIV testing is the first step towards maintaining a healthy life.

The Center for Disease Control and Prevention (CDC) suggests that everyone between the age of 13 and 64 should get tested for HIV at least once as part of their routine check-up. Moreover, people diagnosed with HIV should start treatment with antiretroviral therapy or ART. Not to mention, a large part of the fight against HIV globally has been raising awareness amongst people about the disease, including its diagnosis & testing and adoption of preventative drugs. To that effect, numerous non-governmental organizations are taking initiatives to spread awareness about HIV.

For instance, the Joint United Nations Programme on HIV/AIDS is a global unit that is leading the effort to wipe off the infection by 2030 internationally as part of its Sustainable Development Goals. For this purpose, the organization offers strategic direction, coordination, advocacy, and technical support to assist in connecting and catalyzing leadership from governments, communities, and private sector to provide life-saving HIV services. As a result, ongoing R&D activities in HIV diagnostics, like enhanced sensitivity for early or acute detection of the infection have created massive growth opportunities for the industry.

Overall, the HIV diagnostics market has been segregated in terms of test type, end-use and region. With reference to test type, the market has been classified into viral load test, antibody test, and CD4 tests. Among these, the antibody test segment held a market share of about 5% in 2021 and is poised to exhibit sturdy growth over 2022-2028. The growth of this segment is mainly due to the surging number of infections in underdeveloped and developing nations.

Based on end-use, the HIV diagnostics market has been segmented into hospitals & clinics, diagnostic laboratories, home settings, and others. The home settings segment is likely to depict a CAGR of more than 1.1% between 2022 and 2028 driven by the development of new in-home testing products.

From the regional point, the North America HIV diagnostics market exceeded a valuation of USD 60 million in 2021 and is set to observe moderate growth through the forecast period. Declining HIV cases are speculated to impede regional market growth.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definitions
    • 1.2.1 North America
    • 1.2.2 Europe
    • 1.2.3 Asia Pacific
    • 1.2.4 Latin America
    • 1.2.5 Middle East
    • 1.2.6 Africa
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 HIV diagnostics industry 360 degree synopsis
    • 2.1.1 Business trends
    • 2.1.2 Test type trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 HIV Diagnostics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Favorable regulatory landscape in U
      • 3.3.1.2 Point of Care (P-o-C) HIV diagnostics development
      • 3.3.1.3 Increasing HIV prevalence in low and middle-income countries
      • 3.3.1.4 Increasing government initiatives for HIV awareness
    • 3.3.2 Industry pitfalls and challenges
      • 3.3.2.1 Low degree of penetration in undeveloped regional markets
      • 3.3.2.2 Growing awareness regarding HIV transmission and testing
      • 3.3.2.3 Reduction of HIV cases in developed countries
  • 3.4 Growth potential analysis
    • 3.4.1 By test type
    • 3.4.2 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2021
    • 3.8.1 Competitive matrix analysis, 2021
  • 3.9 PESTEL analysis

Chapter 4 HIV Diagnostics Market, By Test Type

  • 4.1 Key segment trends
  • 4.2 Antibody test
    • 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.3 Viral load test
    • 4.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.4 CD4 test
    • 4.4.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 5 HIV Diagnostics Market, By End-use

  • 5.1 Key segment trends
  • 5.2 Diagnostic laboratories
    • 5.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.3 Hospitals & clinics
    • 5.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.4 Home settings
    • 5.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 6 HIV Diagnostics Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 Market size, by country 2017 - 2028 (USD Million)
    • 6.2.2 Market size, by test type, 2017 - 2028 (USD Million)
    • 6.2.3 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.2.4 U.S.
      • 6.2.4.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.2.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.2.5 Canada
      • 6.2.5.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.2.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
  • 6.3 Europe
    • 6.3.1 Market size, by country 2017 - 2028 (USD Million)
    • 6.3.2 Market size, by test type, 2017 - 2028 (USD Million)
    • 6.3.3 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.3.4 Russia
      • 6.3.4.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.3.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.3.5 France
      • 6.3.5.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.3.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.3.6 Spain
      • 6.3.6.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.3.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.3.7 Italy
      • 6.3.7.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.3.7.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.3.8 UK
      • 6.3.8.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.3.8.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.3.9 Germany
      • 6.3.9.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.3.9.2 Market size, by end-use, 2017 - 2028 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market size, by country 2017 - 2028 (USD Million)
    • 6.4.2 Market size, by test type, 2017 - 2028 (USD Million)
    • 6.4.3 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.4.4 India
      • 6.4.4.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.4.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.4.5 China
      • 6.4.5.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.4.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market size, by country 2017 - 2028 (USD Million)
    • 6.5.2 Market size, by test type, 2017 - 2028 (USD Million)
    • 6.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.5.4 Brazil
      • 6.5.4.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.5.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.5.5 Mexico
      • 6.5.5.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.5.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.5.6 Argentina
      • 6.5.6.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.5.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
  • 6.6 Middle East
    • 6.6.1 Market size, by country 2017 - 2028 (USD Million)
    • 6.6.2 Market size, by test type, 2017 - 2028 (USD Million)
    • 6.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.6.4 Iran
      • 6.6.4.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.6.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.6.5 Saudi Arabia
      • 6.6.5.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.6.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.6.6 Yemen
      • 6.6.6.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.6.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
  • 6.7 Africa
    • 6.7.1 Market size, by country 2017 - 2028 (USD Million)
    • 6.7.2 Market size, by test type, 2017 - 2028 (USD Million)
    • 6.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.7.4 South Africa
      • 6.7.4.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.7.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.7.5 Mozambique
      • 6.7.5.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.7.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.7.6 Nigeria
      • 6.7.6.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.7.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.7.7 United Republic of Tanzania
      • 6.7.7.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.7.7.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.7.8 Kenya
      • 6.7.8.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.7.8.2 Market size, by end-use, 2017 - 2028 (USD Million)
    • 6.7.9 Uganda
      • 6.7.9.1 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.7.9.2 Market size, by end-use, 2017 - 2028 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Strategy dashboard, 2021
  • 7.2 Abbott
    • 7.2.1 Business overview
    • 7.2.2 Financial data
    • 7.2.3 Product landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 OraSure Technologies.
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Product landscape
    • 7.3.4 Strategic outlook
    • 7.3.5 SWOT analysis
  • 7.4 BD
    • 7.4.1 Business overview
    • 7.4.2 Financial data
    • 7.4.3 Product landscape
    • 7.4.4 Strategic outlook
    • 7.4.5 SWOT analysis
  • 7.5 BIONEER CORPORATION
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Product landscape
    • 7.5.4 Strategic outlook
    • 7.5.5 SWOT analysis
  • 7.6 bioMérieux SA
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Product landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 ChemBio Diagnostics Inc.
    • 7.7.1 Business overview
    • 7.7.2 Financial data
    • 7.7.3 Product landscape
    • 7.7.4 Strategic outlook
    • 7.7.5 SWOT analysis
  • 7.8 Qiagen
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Product landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 Roche Diagnostics
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Product landscape
    • 7.9.4 Strategic outlook
    • 7.9.5 SWOT analysis
  • 7.10 Cepheid
    • 7.10.1 Business overview
    • 7.10.2 Financial data
    • 7.10.3 Product landscape
    • 7.10.4 Strategic outlook
    • 7.10.5 SWOT analysis
  • 7.11 Omega Diagnostics
    • 7.11.1 Business overview
    • 7.11.2 Financial data
    • 7.11.3 Product landscape
    • 7.11.4 Strategic outlook
    • 7.11.5 SWOT analysis